Amneal Pharmaceuticals, Inc. AMRX Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s tax on share settlement?
- Amneal Pharmaceuticals, Inc. (AMRX) reported tax on share settlement of $44.31M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s tax on share settlement changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s tax on share settlement increased by 104.7% year-over-year, from $21.64M to $44.31M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s tax on share settlement?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s tax on share settlement has grown at a 70.1% compound annual growth rate (CAGR), from $2.66M to $22.28M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.